Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€42.60
01.11.22
€55.00
31.12.24
-10.33%
04.11.22

Could be very worthwhile Investment >20% year
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€88.01
01.11.22
€100.00
31.12.24
13.11%
05.05.23

Could be worthwhile Investment >10% per year
buy
GSK plc

Start price
Target price
Perf. (%)
€16.86
01.11.22
€25.00
31.12.24
-0.27%
05.05.23

Could be worthwhile Investment >10% per year
Acorda Therapeutics Cdt

Start price
Target price
Perf. (%)
€1.11
31.10.22
-
31.10.23
-33.33%
04.11.22

Could be very worthwhile Investment >20% year
buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.47
31.10.22
€18.00
31.12.24
19.77%
31.10.22

Could be very worthwhile Investment >20% year
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€269.40
31.10.22
-
31.10.23
-20.19%
14.05.23

buy
First Wave BioPharma Inc.

Start price
Target price
Perf. (%)
€10.49
31.10.22
-
31.10.23
-44.13%
12.11.22

buy
Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€74.00
30.10.22
-
30.10.23
-6.08%
12.11.22

buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€41.88
30.10.22
-
30.10.23
72.11%
18.05.23

buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€2.45
30.10.22
-
30.10.23
-3.39%
12.11.22

buy
Immunic Inc.

Start price
Target price
Perf. (%)
€1.83
30.10.22
-
30.10.23
-22.71%
12.11.22

Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€74.00
30.10.22
-
30.10.23
156.76%
19.12.22

buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.50
30.10.22
-
30.10.23
-8.00%
12.11.22

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€362.80
29.10.22
€400.00
29.10.23
6.95%
05.05.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€316.75
29.10.22
-
29.11.22
-3.65%
30.11.22

buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.08
29.10.22
-
29.10.23
-16.54%
12.11.22

Seres Therapeutics Inc

Start price
Target price
Perf. (%)
€9.04
29.10.22
€4.00
29.10.23
-23.77%
12.11.22

Theradiag S.A.

Start price
Target price
Perf. (%)
€2.30
29.10.22
€1.00
29.10.23
-1.09%
12.11.22

buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€2.68
29.10.22
€12.00
29.10.23
-31.29%
23.01.23

buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€2.68
29.10.22
-
29.10.23
40.63%
30.10.23

Could be worthwhile Investment >10% per year
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€79.55
28.10.22
-
28.11.22
3.51%
29.11.22

buy
GSK plc

Start price
Target price
Perf. (%)
€16.72
28.10.22
-
28.10.23
2.14%
18.05.23

Risky Investment
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€85.88
28.10.22
-
28.10.23
16.27%
18.05.23

Risky Investment
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€78.68
28.10.22
-
28.10.23
-7.17%
18.05.23

Risky Investment
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€301.55
28.10.22
-
28.10.23
-10.79%
01.01.23

Risky Investment